In this multi-jurisdictional guide, explore an overview of key legal issues, rules and developments regarding AI, machine learning, and big data across a range of jurisdictions.
Some topics covered in this resource include a framework for understanding artificial intelligence and more.
In this multi-country guide, learn about key laws regarding insurance and insurers in a wide range of jurisdictions. This resource was originally published on the website of CMS on January 31, 2023, and last updated May 19, 2023.
This guide provides an overview of cryptoasset regulation (prior to the introduction of MiCA), focussing at this point on European jurisdictions, both inside and outside the EU. It summarizes the regulations applying to the main activities performed by cryptoasset service providers and the requirements of the licensing regimes, including time and cost.
As smoke from wildfires in Canada drift through Canadian provinces and the United States, what facts and tips should in-house counsel consider? Learn from this curated selection or resources.
This guide provides corporate counsel and international practitioners with comprehensive jurisdiction-by-jurisdiction guidance to product liability laws and regulation.
In this multi-jurisdictional guide, explore an overview of key legal issues, rules and developments regarding employment and labor across a range of jurisdictions.
Learn about key implications of the Spring 2023 situation that saw the United States reach its national debt ceiling.
For legal professionals, caution and conservatism are often vital in fulfilling their job responsibilities. Discretion and thoroughness are required to protect clients’ best interests. So it’s no wonder that many in the legal field are hesitant to adopt new, untested technologies. Even with potential benefits on the horizon, the risk of using tools that haven't been fully vetted can be enough to slow down innovation. Read more here.
This article discusses the critical decisions that are pending before courts and legislators in 2023 that promise to shape the future of the 340B Drug Pricing Program (340B Program), which provides discounts on outpatient drugs for certain health care providers, referred to as “covered entities.” The resolution of these issues will have an enormous financial impact on the health care industry, including pharmaceutical manufacturers, 340B hospitals, and federal grantees.
This blog explores the U.S. Food & Drug Administration (FDA) two final guidance documents to assist with transitioning medical devices: (i) that were subject to certain enforcement policies issued during the COVID-19 Public Health Emergency (PHE), and (ii) that were issued emergency use authorizations (EUAs). These guidance documents finalize the corresponding draft guidance documents that were issued on December 23, 2021.